Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
KFSHRC Showcases Medical Education Innovations at AMEE 2024 Switzerland
RIYADH, Saudi Arabia, Aug.20, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is further expanding its global footprint by participating in the 2024 International Association for Medical Education in Europe (AMEE) Conference for the second consecutive year. Taking place from August 26 to 28 in Basel, Switzerland, this event brings together global leaders in medical education and healthcare. This year, KFSHRC's focus is on refining clinical...
Nasdaq GlobeNewswire
20/08/2024
Surgical Sponges Market worth $1.19 billion in 2029 driven by Technological…
Browse in-depth TOC on "Surgical Sponges Market" Browse in-depth TOC on "Surgical Sponges Market" 328 - Tables 44 - Figures 286 - Pages Johnson & Johnson Services, Inc.: Market Leader in Surgical Sponges Johnson & Johnson Services, Inc. (US) is a dominant player in the surgical sponges market, holding the largest market share in 2023. The company manufactures and distributes a wide range of healthcare products acrossNorth America,Europe, theMiddle East...
PR Newswire
20/08/2024
Heart Attack Diagnostics Market to Reach $21.1 Billion, Globally, by 2033 at…
Request Sample of the Report on Heart Attack Diagnostics Market Forecast 2033 - https://www.alliedmarketresearch.com/request-sample/A12689 Request Sample of the Report on Heart Attack Diagnostics Market Forecast 2033 -https://www.alliedmarketresearch.com/request-sample/A12689 Prime determinants of growth The heart attack diagnostics market is experiencing significant growth driven by several key factors such as advancements in medical imaging technologies have revolutionized...
PR Newswire
20/08/2024
Orion Corporation: Managers' transactions – Liisa Hurme
ORION CORPORATIONMANAGERS' TRANSACTIONS20 AUGUST 2024 at 16.15 EEST Orion Corporation: Managers' transactions – Liisa Hurme Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.Orion Oyj - Managers' Transactions ____________________________________________ Person subject to the notification...
Nasdaq GlobeNewswire
20/08/2024
Carilion Clinic further expands quality cardiac care access with latest Philips…
Integrated Philips cardiovascular solutions enhance the patient & staff experience with reduced X-ray dose & procedure time for more time with patients and to help improve outcomes New facility will have 11 specialized Philips interventional suites, allowing physicians to treat patients with complex cardiovascular conditions closer to home Amsterdam, The Netherlands and Roanoke, US – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and...
Nasdaq GlobeNewswire
20/08/2024
iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES…
Late Breaking Oral Presentation Details Title : Interim Analysis of GALAXIES Lung-201: Phase 2, Randomized, Open-label Platform Study of Belrestotug Plus Dostarlimab in Patients (pts) With Previously Untreated Locally Advanced/Metastatic (LA/M) PD-L1 High (TPS >/=50%) Non-Small Cell Lung Cancer (NSCLC)Abstract Number : LBA52Session Title : Proffered Paper Session: NSCLC MetastaticDate / Time : September 14, 2024 at 8:30 am CEST / 2:30 am ETThe ESMO website indicates that all...
Nasdaq GlobeNewswire
20/08/2024
Roche responds to WHO's declaration of a global health emergency due to the…
Roche is committed to supporting all those working to overcome the mpox outbreak by providing access to high-quality Polymerase Chain Reaction (PCR) testingRoche confirms that its cobas MPXV test, as well as the LightMix® research use only kits, detect the latest mpox virus variants It is actively working to enhance laboratory testing capacity for mpox worldwideBasel, 20 August 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it is supporting the international...
Nasdaq GlobeNewswire
20/08/2024
Infectious Disease Expert Kelly Warfield Named Sabin's New R&D President
caption: Sabin Vaccine Institute Research & Development President Kelly Warfield WASHINGTON, Aug.20, 2024(GLOBE NEWSWIRE) -- Virologist and vaccine development leader Kelly Warfield has joined the Sabin Vaccine Institute as its Research & Development President to drive Sabin's current candidate vaccines toward licensure and expand its pipeline.A member of Sabin's executive team, Warfield will manage the R&D program and team, collaborating with peers, cross-functional...
Nasdaq GlobeNewswire
20/08/2024
MAHE signs MoU with SKAN and Happiest Health for academics, research and…
Mr. Ashok Soota, Chairman & Managing Trustee of SKAN, said, "We are delighted that Manipal Academy of Higher Education (MAHE) has agreed to sign an agreement covering R&D and academic collaboration with SKAN and also an agreement to provide consultancy to Happiest Health, for various healthcare practices. MAHE is a powerhouse with vast years of experience in academics, research, and multiple healthcare practices. We look forward to advancing the frontiers of science through…
PR Newswire
20/08/2024
Extracorporeal Membrane Oxygenation Machine (ECMO) Market to Reach $793.7…
Request Sample of the Report on Extracorporeal Membrane Oxygenation Machine (ECMO) Market Forecast 2033 - https://www.alliedmarketresearch.com/request-sample/A284556 Request Sample of the Report on Extracorporeal Membrane Oxygenation Machine (ECMO) Market Forecast 2033 -https://www.alliedmarketresearch.com/request-sample/A284556 Prime determinants of growth The global extracorporeal membrane oxygenation (ECMO) machine market is experiencing growth due to several factors such...
PR Newswire
20/08/2024
Controlled Clinical Trial Results for FDA-Approved Tinnitus Treatment Device…
The published paper is available at: https://www.nature.com/articles/s41467-024-50473-z The published paper is available at:https://www.nature.com/articles/s41467-024-50473-z Lenire is a bimodal neuromodulation device which has been shown to provide relief from tinnitus that can sustain for at least 12-months after treatment in large-scale clinical trials. [2],[3]Lenire's bimodal neuromodulation pairs mild electrical pulses to the tongue through an intra-oral component called the...
PR Newswire
20/08/2024
Step Machines Market to Reach $1.8 Billion, Globally, by 2033 at 3.2% CAGR…
Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/4281 Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/4281 Prime determinants of growth The step machines market is mostly driven by rise in health consciousness and the popularity of at-home exercise. In addition, demand for step machines is driven by growing awareness of physical fitness and wellness among as well as the ease of at-home...
PR Newswire
20/08/2024
Adcendo ApS and Multitude Therapeutics Inc. Announce Global Development and…
TF is a clinically validated ADC target that is highly expressed in indications such as non-small cell lung cancer, colorectal cancer, cervical cancer, oesophageal cancer, head and neck cancer, bladder cancer and certain gastrointestinal cancers, but its expression is limited in normal tissues. TF is a clinically validated ADC target that is highly expressed in indications such as non-small cell lung cancer, colorectal cancer, cervical cancer, oesophageal cancer, head and neck cancer, bladder...
PR Newswire
20/08/2024
Implantica announces RefluxStop™ pivotal 4-year study results published in the…
At 4-year follow-up, patients experienced 90% improvement in GERD Health-Related Quality of Life (GERD-HRQL questionnaire) score, with no patients requiring daily medical therapy for acid reflux. 46/47 patients had no swallowing problems (dysphagia) at follow-up compared to 11 cases of mixed severity of dysphagia before surgery, which is one of the most common complications with standard of care procedures usually reaching about 30% at 5-year follow-up. No patient was dissatisfied because of…
PR Newswire
20/08/2024
New Electrolux Group study shows short wash and low temperature key to reducing…
Through extensive laboratory testing, different washing methods were tested on various fabrics, selected to represent common clothing types including denim jeans and cotton T-shirts. Color degradation was regularly monitored and over 600 panelists determined the point at which clothes would be disposed of. Through extensive laboratory testing, different washing methods were tested on various fabrics, selected to represent common clothing types including denim jeans and cotton T-shirts...
PR Newswire
20/08/2024
Bone Index Announces Successful Financing Round and Strategic Partnership with…
About Lynx Financial About Lynx Financial Lynx Financial is a boutique investment and investment banking firm that specializes in Life Sciences and Medical Technology sectors. With a global outreach and on-the-ground presence, Lynx Financial fully leverages its expertise in deal structuring and investments to help emerging innovative companies from around the world gain access to funding and strategic resources inAsia Pacificregions. For more information: Bone Index:Janne...
PR Newswire
20/08/2024
BerGenBio Collaborates with Tempus to Potentially Accelerate Development in…
Upon conclusion of the BGBC016 study, the parties intend to present insights derived from the resulting data to appropriate regulatory agencies as a next step in the further development of bemcentinib. Upon conclusion of the BGBC016 study, the parties intend to present insights derived from the resulting data to appropriate regulatory agencies as a next step in the further development of bemcentinib. Martin Olin, CEO of BerGenBio, expressed enthusiasm about the collaboration, stating…
PR Newswire
20/08/2024
Coloplast A/S - Interim Financial Report, 9M 2023/24
9M 2023/24 Interim financial results, 9M 2023/241 October 2023 - 30 June 2024 Coloplast delivered 8% organic growth and an EBIT margin 1)of 27% in Q3, with 11% growth in absolute EBIT 1). Reported revenue in DKK grew 13% which includes 4%-points contribution from Kerecis (underlying growth of around 35%).Organic growth rates by business area: Ostomy Care 8%, Continence Care 8%, Voice and Respiratory Care 11%, Advanced Wound Care 13% (Advanced Wound Dressings 13%) and...
Nasdaq GlobeNewswire
20/08/2024
Akari Therapeutics Reports Second Quarter 2024 Financial Results and Recent…
Samir R. Patel, M.D. Appointed Interim CEO; Interim CEO Employment Contract Demonstrates Alignment with Shareholders Plan for Prioritization of Peak Bio's ADC Cancer Therapeutic Platform Technology and Akari's PAS-nomacopan for Geographic Atrophy Existing Investors Support the Company with Issuance of $1 Million in Unsecured Convertible Notes Secured $7.6 Million in Upsized Financing RoundReceives Positive and Constructive Pre-IND Feedback from US FDA for...
Nasdaq GlobeNewswire
19/08/2024
TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the…
Company Announcement TEPKINLYis the first and only subcutaneous bispecific antibody approved as a monotherapy in the European Union to treat both relapsed or refractory (R/R) follicular lymphoma (FL) and R/R diffuse large B-cell lymphoma (DLBCL), after two or more lines of systemic therapy COPENHAGEN, Denmark; August 19, 2024 –Genmab A/S(Nasdaq: GMAB)today announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY ®...
Nasdaq GlobeNewswire
19/08/2024
Crossject appoints Tony Tipton as U.S. Chief Operating Officer in Preparation…
Press Release Crossject appoints Tony Tipton as U.S. Chief Operating Officer in Preparation for Commercialization of ZEPIZURE® Epilepsy Rescue Treatment Experienced executive to lead preparations for U.S. commercialization of ZEPIZURE®Reinforces and de-risks pre-commercial activities ahead of submitting marketing authorization application for ZEPIZURE® epilepsy rescue treatment in the U.S.Dijon, France August 19, 2024 17:30 CET-- Crossject (ISIN: FR0011716265; Euronext:...
Nasdaq GlobeNewswire
19/08/2024
Health Insurance Market to Reach $6.2 Trillion, Globally, by 2032 at 9.8% CAGR…
Get Your Sample Report & TOC Today: https://www.alliedmarketresearch.com/request-sample/4338 Get Your Sample Report & TOC Today: https://www.alliedmarketresearch.com/request-sample/4338 Prime Determinants of Growth The aging population, growing prevalence of chronic diseases, and growing healthcare expenditures are the main factors influencing the growth of the health insurance market. Insurance is crucial for people and families to be able to afford the care they need due...
PR Newswire
19/08/2024
Real-world Evidence Solutions Market to be Worth $6.37 Billion by…
Clinical evidence obtained from the examination of real-world data (RWD) is known as real-world evidence (RWE). The resulting clinical evidence covers the use of a medical product and its possible advantages or disadvantages. Pharmaceutical, biotechnology, and medical device firms, as well as healthcare payers and providers, employ RWE solutions for market access and reimbursement/coverage choices, drug development and approvals, post-market surveillance, and medical device development and…
PR Newswire
19/08/2024
Healthcare, Technology Leaders Gather in Johannesburg for Healthcare Innovation…
Key Topics and Agenda Highlights Key Topics and Agenda Highlights The summit will address critical challenges in African healthcare, focusing on technology's role in achieving universal healthcare. Key topics include: Key Speakers HISA 2024 will feature industry experts discussing digital health, telemedicine, and AI integration. Notable speakers include: Sponsorship and Exhibition Opportunities HISA 2024 offers IT service providers, HealthTech startups, and medical device...
PR Newswire
19/08/2024
Altri Comunicati
